The emerging biology of muscle stem cells: Implications for cell-based therapies

BioEssays

Volumn 35, Issue 3, 2013, Pages 231-241

  Bentzinger, C Florian ^a   Wang, Yu Xin ^a,b   von Maltzahn, Julia ^a   Rudnicki, Michael A ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Myogenesis; PAX7; Satellite cells; Stem cells; Therapy

Indexed keywords

TRANSCRIPTION FACTOR PAX7;

ARTICLE; CELL HETEROGENEITY; CELL THERAPY; CELL TYPE; MUSCLE CELL; MUSCLE DEVELOPMENT; SATELLITE CELL; STEM CELL;

ANIMALS; CELL COMMUNICATION; HUMANS; MUSCLE, SKELETAL; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL NICHE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84873569965     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200063     Document Type: Article

References (112)

1. Schiaffino S, Reggiani C. 2011. Fiber types in mammalian skeletal muscles. Physiol Rev 91: 1447-531.
2. Pette D. 2001. Historical perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 90: 1119-24.
3. Rüegg MA, Glass DJ. 2011. Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51: 373-95.
4. Campbell KP, Stull JT. 2003. Skeletal muscle basement membrane-sarcolemma-cytoskeleton interaction minireview series. J Biol Chem 278: 12599-600.
5. Dalkilic I, Kunkel LM. 2003. Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 13: 231-8.
6. Goyenvalle A, Seto JT, Davies KE, Chamberlain J. 2011. Therapeutic approaches to muscular dystrophy. Hum Mol Genet 20: R69-78.
7. Negroni E, Vallese D, Vilquin JT, Butler-Browne G, et al. 2011. Current advances in cell therapy strategies for muscular dystrophies. Expert Opin Biol Ther 11: 157-76.
8. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, et al. 1989. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337: 176-9.
9. Decary S, Mouly V, Hamida CB, Sautet A, et al. 1997. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8: 1429-38.
10. Nguyen HX, Tidball JG. 2003. Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol 547: 125-32.
11. Nguyen HX, Tidball JG. 2003. Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol 553: 833-41.
12. Villalta SA, Nguyen HX, Deng B, Gotoh T, et al. 2009. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18: 482-96.
13. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, et al. 2011. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1: 21.
14. Valdez G, Tapia JC, Kang H, Clemenson GD, Jr, et al. 2010. Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci USA 107: 14863-8.
15. Rando TA. 2006. Stem cells, ageing and the quest for immortality. Nature 441: 1080-6.
16. Kuang S, Gillespie MA, Rudnicki MA. 2008. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2: 22-31.
17. Joe AW, Yi L, Natarajan A, Le Grand F, et al. 2010. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12: 153-63.
18. Tidball JG, Villalta SA. 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298: R1173-87.
19. Mounier R, Chretien F, Chazaud B. 2011. Blood vessels and the satellite cell niche. Curr Top Dev Biol 96: 121-38.
20. Bentzinger CF, Wang YX, Rudnicki MA. 2012. Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4: pii: a008342.
21. Montarras D, Morgan J, Collins C, Relaix F, et al. 2005. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309: 2064-7.
22. Sacco A, Doyonnas R, Kraft P, Vitorovic S, et al. 2008. Self-renewal and expansion of single transplanted muscle stem cells. Nature 456: 502-6.
23. Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, et al. 2010. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329: 1078-81.
24. Skuk D, Paradis M, Goulet M, Chapdelaine P, et al. 2010. Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Mol Ther 18: 1689-97.
25. Collins CA, Olsen I, Zammit PS, Heslop L, et al. 2005. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301.
26. Biressi S, Rando TA. 2010. Heterogeneity in the muscle satellite cell population. Semin Cell Dev Biol 21: 845-54.
27. Snow MH. 1983. A quantitative ultrastructural analysis of satellite cells in denervated fast and slow muscles of the mouse. Anat Rec 207: 593-604.
28. Schultz E, Gibson MC, Champion T. 1978. Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J Exp Zool 206: 451-6.
29. Mauro A. 1961. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-5.
30. Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, et al. 2000. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151: 1221-34.
31. Cornelison DD, Filla MS, Stanley HM, Rapraeger AC, et al. 2001. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 239: 79-94.
32. Bernfield M, Gotte M, Park PW, Reizes O, et al. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-77.
33. Pallafacchina G, Francois S, Regnault B, Czarny B, et al. 2010. An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells. Stem Cell Res 4: 77-91.
34. Rudnicki MA, Le Grand F, McKinnell I, Kuang S. 2008. The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 3: 323-31.
35. Siegel AL, Atchison K, Fisher KE, Davis GE, et al. 2009. 3D timelapse analysis of muscle satellite cell motility. Stem Cells 27: 2527-38.
36. Hall JK, Banks GB, Chamberlain JS, Olwin BB. 2010. Prevention of muscle aging by myofiber-associated satellite cell transplantation. Sci Trans Med 2: 57ra83.
37. Watt DJ, Morgan JE, Clifford MA, Partridge TA. 1987. The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat Embryol 175: 527-36.
38. Gawlik KI, Durbeej M. 2011. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle 1: 9.
39. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA. 2005. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J 19: 934-42.
40. Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, et al. 2011. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138: 3625-37.
41. Lander AD, Kimble J, Clevers H, Fuchs E, et al. 2012. What does the concept of the stem cell niche really mean today? BMC Biol 10: 19.
42. Kanazawa S, Fujiwara T, Matsuzaki S, Shingaki K, et al. 2010. bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing. PLoS One 5: e12228.
43. Abou-Khalil R, Mounier R, Chazaud B. 2010. Regulation of myogenic stem cell behavior by vessel cells: the "menage a trois" of satellite cells, periendothelial cells and endothelial cells. Cell Cycle 9: 892-6.
44. Abou-Khalil R, Le Grand F, Pallafacchina G, Valable S, et al. 2009. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell 5: 298-309.
45. Axelrod HR. 1984. Embryonic stem cell lines derived from blastocysts by a simplified technique. Dev Biol 101: 225-8.
46. Fukada S, Uezumi A, Ikemoto M, Masuda S, et al. 2007. Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells 25: 2448-59.
47. Wen Y, Bi P, Liu W, Asakura A, et al. 2012. Constitutive notch activation upregulates pax7 and promotes the self-renewal of skeletal muscle satellite cells. Mol Cell Biol 32: 2300-11.
48. Mourikis P, Sambasivan R, Castel D, Rocheteau P, et al. 2012. A critical requirement for notch signaling in maintenance of the quiescent skeletal muscle stem cell state. Stem Cells 30: 243-52.
49. Pisconti A, Cornelison DD, Olguin HC, Antwine TL, et al. 2010. Syndecan-3 and Notch cooperate in regulating adult myogenesis. J Cell Biol 190: 427-41.
50. Mandal PK, Blanpain C, Rossi DJ. 2011. DNA damage response in adult stem cells: pathways and consequences. Nat Rev Mol Cell Biol 12: 198-202.
51. Wang YX, Rudnicki MA. 2011. Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol 13: 127-33.
52. Bentzinger CF, von Maltzahn J, Rudnicki MA. 2010. Extrinsic regulation of satellite cell specification. Stem Cell Res Ther 1: 27.
53. Halevy O, Piestun Y, Allouh MZ, Rosser BW, et al. 2004. Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn 231: 489-502.
54. Zammit PS, Golding JP, Nagata Y, Hudon V, et al. 2004. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol 166: 347-57.
55. Edmondson DG, Olson EN. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 3: 628-40.
56. Olguin HC, Yang Z, Tapscott SJ, Olwin BB. 2007. Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. J Cell Biol 177: 769-79.
57. Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, et al. 2011. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138: 3647-56.
58. Allbrook DB, Han MF, Hellmuth AE. 1971. Population of muscle satellite cells in relation to age and mitotic activity. Pathology 3: 223-43.
59. Schultz E. 1974. A quantitative study of the satellite cell population in postnatal mouse lumbrical muscle. Anat Rec 180: 589-95.
60. Lepper C, Partridge TA, Fan CM. 2011. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138: 3639-46.
61. Rantanen J, Hurme T, Lukka R, Heino J, et al. 1995. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest 72: 341-7.
62. Schultz E. 1996. Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 175: 84-94.
63. Conboy MJ, Karasov AO, Rando TA. 2007. High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol 5: e102.
64. Shinin V, Gayraud-Morel B, Gomes D, Tajbakhsh S. 2006. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol 8: 677-87.
65. Kuang S, Kuroda K, Le Grand F, Rudnicki MA. 2007. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129: 999-1010.
66. Heslop L, Morgan JE, Partridge TA. 2000. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113 (Pt 12): 2299-308.
67. Collins CA, Zammit PS, Ruiz AP, Morgan JE, et al. 2007. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 25: 885-94.
68. Gayraud-Morel B, Chretien F, Jory A, Sambasivan R, et al. 2012. Myf5 haploinsufficiency reveals distinct cell fate potentials for adult skeletal muscle stem cells. J Cell Sci 125 (Pt 7): 1738-49.
69. Le Grand F, Jones AE, Seale V, Scimè A, et al. 2009. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4: 535-47.
70. Yablonka-Reuveni Z. 2011. The skeletal muscle satellite cell: still young and fascinating at 50. J Histochem Cytochem 59: 1041-59.
71. Braun T, Rudnicki MA, Arnold HH, Jaenisch R. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71: 369-82.
72. Tanaka KK, Hall JK, Troy AA, Cornelison DD, et al. 2009. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 4: 217-25.
73. Rocheteau P, Gayraud-Morel B, Siegl-Cachedenier I, Blasco MA, et al. 2012. A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell 148: 112-25.
74. Skuk D, Paradis M, Goulet M, Tremblay JP. 2007. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation 84: 1307-15.
75. Pellegrini KL, Beilharz MW. 2010. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected. Transplantation 91: 522-6.
76. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. 1999. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144: 1113-22.
77. De Angelis L, Berghella L, Coletta M, Lattanzi L, et al. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147: 869-78.
78. Minasi MG, Riminucci M, De Angelis L, Borello U, et al. 2002. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129: 2773-83.
79. Wang L, Kamath A, Frye J, Iwamoto GA, et al. 2012. Aorta-derived mesoangioblasts differentiate into the oligodendrocytes by inhibition of the Rho kinase signaling pathway. Stem Cells Dev 21: 1069-89.
80. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, et al. 2010. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120: 11-9.
81. Tedesco FS, Hoshiya H, D'Antona G, Gerli MF, et al. 2011. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci Trans Med 3: 96ra78.
82. Dellavalle A, Maroli G, Covarello D, Azzoni E, et al. 2011. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun 2: 499.
83. Torrente Y, Belicchi M, Sampaolesi M, Pisati F, et al. 2004. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114: 182-95.
84. Benchaouir R, Meregalli M, Farini A, D'Antona G, et al. 2007. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1: 646-57.
85. Negroni E, Riederer I, Chaouch S, Belicchi M, et al. 2009. In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 17: 1771-8.
86. Shi M, Ishikawa M, Kamei N, Nakasa T, et al. 2009. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells 27: 949-60.
87. Zheng B, Cao B, Crisan M, Sun B, et al. 2007. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25: 1025-34.
88. Vauchez K, Marolleau JP, Schmid M, Khattar P, et al. 2009. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther 17: 1948-58.
89. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, et al. 2010. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12: 257-66.
90. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA. 2002. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159: 123-34.
91. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-30.
92. LaBarge MA, Blau HM. 2002. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111: 589-601.
93. Mackenzie TC, Shaaban AF, Radu A, Flake AW. 2002. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg 37: 1058-64.
94. Gang EJ, Darabi R, Bosnakovski D, Xu Z, et al. 2009. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Exp Cell Res 315: 2624-36.
95. Xynos A, Corbella P, Belmonte N, Zini R, et al. 2010. Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway. Stem Cells 28: 965-73.
96. Barberi T, Bradbury M, Dincer Z, Panagiotakos G, et al. 2007. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642-8.
97. Darabi R, Santos FN, Filareto A, Pan W, et al. 2011. Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells 29: 777-90.
98. Darabi R, Pan W, Bosnakovski D, Baik J, et al. 2011. Functional myogenic engraftment from mouse iPS cells. Stem Cell Rev 7: 948-57.
99. Knoepfler PS. 2009. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27: 1050-6.
100. Law PK, Goodwin TG, Wang MG. 1988. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 11: 525-33.
101. Daston G, Lamar E, Olivier M, Goulding M. 1996. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122: 1017-27.
102. Ikemoto M, Fukada S, Uezumi A, Masuda S, et al. 2007. Autologous transplantation of SM/C-2.6(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice. Mol Ther 15: 2178-85.
103. Bachrach E, Perez AL, Choi YH, Illigens BM, et al. 2006. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve 34: 44-52.
104. Asakura A, Rudnicki MA. 2002. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 30: 1339-45.
105. Berry SE, Liu J, Chaney EJ, Kaufman SJ. 2007. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy. Regen Med 2: 275-88.
106. Sampaolesi M, Blot S, D'Antona G, Granger N, et al. 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-9.
107. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, et al. 2007. Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol Chapter 2: Unit 2B.1.
108. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-4.
109. Goudenege S, Pisani DF, Wdziekonski B, Di Santo JP, et al. 2009. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther 17: 1064-72.
110. Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, et al. 2005. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201: 1397-405.
111. Darabi R, Baik J, Clee M, Kyba M, et al. 2009. Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy. Exp Neurol 220: 212-6.
112. Mizuno Y, Chang H, Umeda K, Niwa A, et al. 2010. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 24: 2245-53.